Regenerative MedicineCell reprogramming for aging and disease: animal evidence and early human testing
Cell reprogramming forces cells to change their identity, and this review sorts the field into three approaches. Direct reprogramming converts one mature cell type into another, such as skin cells into neurons. Partial reprogramming briefly switches on youth-restoring factors to reverse aging features without erasing cell identity. Cell fusion merges two cells and can either fuel cancer or power vaccines. In mice, partial reprogramming has extended lifespan and improved tissue repair, and a therapy called ER-100 is the first of its kind cleared by the FDA to start human testing. The authors stress that most evidence is still preclinical. Low efficiency, delivery problems, and long-term tumor risk remain unsolved, and benefits do not prove a cell's identity has changed completely, stably, or safely.